Four months of additional fund-raising netted Mohr Davidow Ventures an extra $29.2 million for three annex funds, according to documents filed last month with the Securities and Exchange Commission.
MDV’s fund-raising effort first came to light in August, when the firm filed SEC documents showing that it had raised a combined $98.1 million in annex funds for its seventh, eighth and ninth core funds. Last month’s updated filings show that its fund-raising efforts raised the total to $127.3 million.
The fund IX annex fund faired the best from the additional effort. It boosted its total to $72.1 million, up from $45.3 million on Aug. 7. The Dec. 3 filing indicates that’s a final close, as the line for “total remaining to be sold” says zero.
MDV had previously raised $580 million for the core fund IX vehicle in September 2007. The additional annex capital brings the total to $652.1 million.
The fund VIII annex fund also got a bit of a boost. It held a final close on $27.9 million, according to the Dec. 3 filing, up from $25.5 in August. MDV had previously raised $400 million for the core fund VIII vehicle in March 2005, so the new total for MDV’s eight fund is $427.9 million.
The firm’s seventh fund did not (or could not) raise any additional capital since August. It held a final close on $27.3 million. With the annex capital, fund VII now totals $477.3 million. MDV actually raised $850 million for its seventh fund back in 2000, but it later reduced the size after the Internet bubble burst.
An MDV spokesperson was not immediately available for comment. —Lawrence AragonDEALWATCH: Five recent investments by Mohr Davidow Ventures
Crescendo Bioscience Inc._Quantitative and objective diagnostic tools
Doxo Inc._Stealth company. No details available.
Genius.com Inc._On-demand personal Web analytics solutions
On-Q-ity Inc._Tools to help doctors treat cancer patients
Tethys Bioscience Inc._Biological markers for clinical diagnostics
Note: Investments made between Nov. 1 and Dec. 7, 2009. Source: Thomson Reuters